Description
Achieve superb RBC, PLT and WBC differentials through near native-state cellular characterization
- Deliver reliable, reportable WBC differential results on the first run, through VCS 360 technology, DataFusion and the enhanced Coulter Principle. These core technologies provide high-resolution characterization without altering cell morphology, providing excellent hematological test results
- Support critical clinical decisions through advanced PLT analysis. The enhanced Coulter Principle provides a reportable MPV—even for thrombocytopenic patients—while DataFusion leverages inter-module intelligence to enable improved flagging and identification of interferences
- Assess anemia with accuracy by maintaining near native-state cellular characterization throughout the RBC maturation cycle
- Facilitate confident slide interpretations through intelligent slide-making. Hemasphere technology analyzes blood viscosity to optimize smearing, and next-generation DxH Slidemaker Stainer II ensures consistent slide quality
Ensure predictable costs and >30% faster break-even point
- Experience low cost of ownership through a 93% first-pass yield and predictable reagent consumption
- Reduce manual interventions with automated maintenance procedures and less reagent turnover to maximize walkaway time
- Utilize a new reportable parameter for the emergency department to identify the possibility of infection earlier to stop potentially deadly complications from developing or progressing, helping to reduce the cost of care
Maximize staff time with the most reportable results per square meter, fewer slide reviews and minimal manual interventions
- Streamline QA/QC processes through customizable, automated technology with daily reminders and remote support
- Optimize operations through a seamless workflow, small footprint, intuitive software and easy maintenance
- Maximize efficiency with one-touch sample processing with total laboratory automation and clinical information management tools
- Save time and improve laboratory workflow through body fluid technology that allows fewer serial dilutions and sample integrity monitoring to minimize risk of spurious results
